Eugen F. Mesaros, Ph.D.

2003 Case Western Reserve University, Cleveland Heights, OH, United States 
organoiron chemistry, organocatalysts
"Eugen Mesaros"
Mean distance: 9.41


Sign in to add mentor
Anthony J. Pearson grad student 2003 Case Western
 (Stereocontrolled functionalization of lateral carbon-carbon double bonds in acyclic pi-allylmolybdenum complexes.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Ott GR, Cheng M, Learn KS, et al. (2016) Discovery of Clinical Candidate CEP-37440, a Selective Inhibitor of Focal Adhesion Kinase (FAK) and Anaplastic Lymphoma Kinase (ALK). Journal of Medicinal Chemistry
Mesaros EF, Angeles TS, Albom MS, et al. (2015) Piperidine-3,4-diol and piperidine-3-ol derivatives of pyrrolo[2,1-f][1,2,4]triazine as inhibitors of anaplastic lymphoma kinase. Bioorganic & Medicinal Chemistry Letters. 25: 1047-52
Mesaros EF, Ott GR, Dorsey BD. (2014) Anaplastic lymphoma kinase inhibitors as anticancer therapeutics: a patent review. Expert Opinion On Therapeutic Patents. 24: 417-42
Dugan BJ, Gingrich DE, Mesaros EF, et al. (2012) A selective, orally bioavailable 1,2,4-triazolo[1,5-a]pyridine-based inhibitor of Janus kinase 2 for use in anticancer therapy: discovery of CEP-33779. Journal of Medicinal Chemistry. 55: 5243-54
Mesaros EF, Thieu TV, Wells GJ, et al. (2012) Strategies to mitigate the bioactivation of 2-anilino-7-aryl-pyrrolo[2,1-f][1,2,4]triazines: identification of orally bioavailable, efficacious ALK inhibitors. Journal of Medicinal Chemistry. 55: 115-25
Wells-Knecht KJ, Ott GR, Cheng M, et al. (2011) 2,7-Disubstituted-pyrrolotriazine kinase inhibitors with an unusually high degree of reactive metabolite formation. Chemical Research in Toxicology. 24: 1994-2003
Ott GR, Wells GJ, Thieu TV, et al. (2011) 2,7-disubstituted-pyrrolo[2,1-f][1,2,4]triazines: new variant of an old template and application to the discovery of anaplastic lymphoma kinase (ALK) inhibitors with in vivo antitumor activity. Journal of Medicinal Chemistry. 54: 6328-41
Zificsak CA, Theroff JP, Aimone LD, et al. (2011) Methanesulfonamido-cyclohexylamine derivatives of 2,4-diaminopyrimidine as potent ALK inhibitors. Bioorganic & Medicinal Chemistry Letters. 21: 3877-80
Mesaros EF, Burke JP, Parrish JD, et al. (2011) Novel 2,3,4,5-tetrahydro-benzo[d]azepine derivatives of 2,4-diaminopyrimidine, selective and orally bioavailable ALK inhibitors with antitumor efficacy in ALCL mouse models. Bioorganic & Medicinal Chemistry Letters. 21: 463-6
Smith AB, Xiong H, Charnley AK, et al. (2010) Design, synthesis, and structural analysis of D,L-mixed polypyrrolinones. 2. Macrocyclic hexapyrrolinones. Organic Letters. 12: 2994-7
See more...